Letter To The Editor

Folinic Acid Supplementation in Autism Spectrum Disorder: Mitigating Safety Concerns Amid Rising Off-Label Use

Volume 64 Publish Date: March 23, 2026
Full Text PDF
DOI
Dua Fatima Sherwani ORCID
Jinnah Sindh Medical University, Karachi, Pakistan
Syeda Abeeha Hasan ORCID
Jinnah Sindh Medical University, Karachi, Pakistan
Dua Ul Khair ORCID
Jinnah Sindh Medical University, Karachi, Pakistan
Aisha Hanif ORCID
Jinnah Sindh Medical University, Karachi, Pakistan
Sherwani, D. F., Hasan, S. A., Khair, D. U., & Hanif, A. (2026). Folinic Acid Supplementation in Autism Spectrum Disorder: Mitigating Safety Concerns Amid Rising Off-Label Use. Neuropsychiatric Investigation, 64, 1–2. https://doi.org/10.5152/NeuropsychiatricInvest.2026.25079
Full Text Full Text PDF

Abstract

-

Similar Articles

Article Info
Published In
Journal Neuropsychiatric Investigation
Volume / Issue Volume 64
Pages 1-2
History
Published Online March 23, 2026
Affiliations
Dua Fatima Sherwani ORCID
Jinnah Sindh Medical University, Karachi, Pakistan
Syeda Abeeha Hasan ORCID
Jinnah Sindh Medical University, Karachi, Pakistan
Dua Ul Khair ORCID
Jinnah Sindh Medical University, Karachi, Pakistan
Aisha Hanif ORCID
Jinnah Sindh Medical University, Karachi, Pakistan
Cite this Article
Sherwani, D. F., Hasan, S. A., Khair, D. U., & Hanif, A. (2026). Folinic Acid Supplementation in Autism Spectrum Disorder: Mitigating Safety Concerns Amid Rising Off-Label Use. Neuropsychiatric Investigation, 64, 1–2. https://doi.org/10.5152/NeuropsychiatricInvest.2026.25079
Share
Outlines